Provider
P53-25 Change to Interim Bill Submission Requirements
Program effective Date: Oct 01, 2025
Program effective Date: Oct 01, 2025
This policy addresses coding and reimbursement for Cellular and Gene Therapy Products. This policy does not apply to FEP.